Michael Lievens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael lievens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Lievens Today - Breaking & Trending Today

First patients enrolled in US trial of nerve stimulation device for IBD

Boomerang Medical announced that the first patients have been enrolled in its U.S. clinical trial assessing the use of nerve stimulation as potential treatment for Crohn’s disease and ulcerative colitis.The FDA granted Boomerang Medical’s bioelectronic device its breakthrough device designation earlier this year for the treatment of inflammatory bowel disease through stimulation of ....

United States , New York , Monica Stonehill , Heather Simonsen , Michael Lievens , Columbia University Irving Medical Center , Kansas Gastroenterology , Boomerang Medical ,

Boomerang Medical Announces First Patients Enrolled in Multi-Center Clinical Trial Evaluating Breakthrough Bioelectronic Device for Inflammatory Bowel Disease

Boomerang Medical Announces First Patients Enrolled in Multi-Center Clinical Trial Evaluating Breakthrough Bioelectronic Device for Inflammatory Bowel Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Marco Zoccali , Heather Simonsen , Pharoah Garma , Michael Lievens , Drug Administration , Infusion Center , Boomerang Medical Inc , Kansas Gastroenterology , Surgery Center , Columbia University Irving Medical Center , Our Research Department , Clinical Trial , Boomerang Medical , Nerve Stimulation Device , Ulcerative Colitis , Inflammatory Bowel Disease , Breakthrough Device Designation , Columbia University Irving Medical , Bowel Disease , University Irving Medical Center , New York City , Ambulatory Surgery Center , Silicon Valley , Fogarty Innovation ,